Merck To Present More Than 30 Data Presentations On Anti-infective Medicines

(RTTNews) - Merck (MRK) announced that researchers are scheduled to present more than 30 scientific data presentations on the company's portfolio of marketed and investigational anti-infective medicines at the 25th European Congress of Clinical Microbiology and Infectious Diseases, April 25-28 in Copenhagen, Denmark.

Merck also reaffirmed its commitment to discovering and developing medicines in the global fight against infectious diseases, including infections caused by resistant bacteria and other pathogens. The company said it is committed to: maintain active R&D programs to address unmet medical needs in the prevention and treatment of infectious disease; monitor antibacterial resistance emergence in collaboration with external partners; support responsible use of antimicrobials to help slow development of resistance and preserve current therapeutic options; and advocate for improvements in regulatory guidance and financial incentives to support and accelerate innovation in the development of new antimicrobials, vaccines, services and solutions.